Xiaonan Kang

515 total citations
23 papers, 375 citations indexed

About

Xiaonan Kang is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Epidemiology. According to data from OpenAlex, Xiaonan Kang has authored 23 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Epidemiology. Recurrent topics in Xiaonan Kang's work include Autophagy in Disease and Therapy (3 papers), Spectroscopy Techniques in Biomedical and Chemical Research (2 papers) and Lipid metabolism and disorders (2 papers). Xiaonan Kang is often cited by papers focused on Autophagy in Disease and Therapy (3 papers), Spectroscopy Techniques in Biomedical and Chemical Research (2 papers) and Lipid metabolism and disorders (2 papers). Xiaonan Kang collaborates with scholars based in China, United States and Australia. Xiaonan Kang's co-authors include Huihui Ren, Huili Dai, Yiran Huang, Yi Ma, Longmei Xu, Xiaohui Feng, Gang Yuan, Fuqing Hu, Bowen Zhou and Lu Zhang and has published in prestigious journals such as PLoS ONE, Analytical Chemistry and Hepatology.

In The Last Decade

Xiaonan Kang

21 papers receiving 366 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaonan Kang China 9 127 103 91 53 42 23 375
Xiaofang Shen China 12 124 1.0× 39 0.4× 63 0.7× 55 1.0× 16 0.4× 25 413
Qin Huang China 11 108 0.9× 46 0.4× 46 0.5× 44 0.8× 30 0.7× 19 368
Qingxia Huang China 11 152 1.2× 56 0.5× 50 0.5× 50 0.9× 73 1.7× 38 359
Sujuan Xu China 13 180 1.4× 24 0.2× 54 0.6× 29 0.5× 34 0.8× 29 406
Angelika Buczyńska Poland 11 158 1.2× 29 0.3× 35 0.4× 26 0.5× 44 1.0× 44 343
Shuan Zhao China 14 205 1.6× 40 0.4× 44 0.5× 92 1.7× 20 0.5× 44 463
Ming Han China 12 199 1.6× 23 0.2× 141 1.5× 46 0.9× 37 0.9× 25 396
Ebru Şener Türkiye 13 69 0.5× 25 0.2× 20 0.2× 39 0.7× 26 0.6× 31 392
Yao Tong China 9 157 1.2× 14 0.1× 51 0.6× 20 0.4× 79 1.9× 22 396
Sha Xu China 7 177 1.4× 16 0.2× 27 0.3× 25 0.5× 87 2.1× 12 385

Countries citing papers authored by Xiaonan Kang

Since Specialization
Citations

This map shows the geographic impact of Xiaonan Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaonan Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaonan Kang more than expected).

Fields of papers citing papers by Xiaonan Kang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaonan Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaonan Kang. The network helps show where Xiaonan Kang may publish in the future.

Co-authorship network of co-authors of Xiaonan Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaonan Kang. A scholar is included among the top collaborators of Xiaonan Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaonan Kang. Xiaonan Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kang, Xiaonan, Xing Zhao, Yuan Zhou, et al.. (2025). Excellent dielectric energy storage properties of Pb-based antiferroelectric ceramics via phase structure regulation and grain engineering. Chemical Engineering Journal. 521. 166739–166739. 2 indexed citations
2.
Zhao, Xing, Fukang Chen, Minghui He, et al.. (2025). Achieving enhanced energy storage performance in Pb-free BNT-based ceramic composite via both high-entropy and grain engineering strategy. Chemical Engineering Journal. 519. 165189–165189. 5 indexed citations
3.
4.
5.
Zhang, Ziyin, Wen Zheng, Xiaonan Kang, et al.. (2024). Mitochondrial SIRT2-mediated CPT2 deacetylation prevents diabetic cardiomyopathy by impeding cardiac fatty acid oxidation. International Journal of Biological Sciences. 21(2). 725–744. 5 indexed citations
6.
Zhang, Ziyin, Xiaohui Feng, Xiaonan Kang, et al.. (2024). Efficacy of rituximab in treating steroid-resistant Graves’ orbitopathy in active moderate-to-severe and sight-threatening forms: A retrospective observation from China. Heliyon. 10(11). e31932–e31932. 1 indexed citations
7.
Li, Qian, Qian Zhao, Xiaoyan Zhang, et al.. (2023). Toward Professionalism of Biobanking in China: A Survey on Working Status, Career Development, Challenges, and Prospects of Biobankers. Biopreservation and Biobanking. 22(2). 139–145. 4 indexed citations
8.
Kang, Xiaonan, et al.. (2023). Advances in cardiovascular-related biomarkers to predict diabetic peripheral neuropathy. World Journal of Diabetes. 14(8). 1226–1233. 4 indexed citations
9.
Kang, Xiaonan, Dan Wang, Lu Zhang, et al.. (2023). Exendin-4 ameliorates tau hyperphosphorylation and cognitive impairment in type 2 diabetes through acting on Wnt/β-catenin/NeuroD1 pathway. Molecular Medicine. 29(1). 118–118. 21 indexed citations
10.
Huang, Chun, Baoli Wang, Xiaonan Kang, et al.. (2022). Valid-NEO: A Multi-Omics Platform for Neoantigen Detection and Quantification from Limited Clinical Samples. Cancers. 14(5). 1243–1243. 5 indexed citations
11.
Yang, Chen, Zhuoan Cheng, Zhicheng Liu, et al.. (2022). Multi-region sequencing with spatial information enables accurate heterogeneity estimation and risk stratification in liver cancer. Genome Medicine. 14(1). 142–142. 19 indexed citations
12.
Ren, Huihui, Fuqing Hu, Dan Wang, et al.. (2021). Sirtuin 2 Prevents Liver Steatosis and Metabolic Disorders by Deacetylation of Hepatocyte Nuclear Factor 4α. Hepatology. 74(2). 723–740. 70 indexed citations
13.
Feng, Xiaohui, Dan Wang, Xiaonan Kang, et al.. (2021). Long Non-coding RNA: A Key Regulator in the Pathogenesis of Diabetic Cardiomyopathy. Frontiers in Cardiovascular Medicine. 8. 655598–655598. 18 indexed citations
14.
Shao, Xiaoguang, Yinjie Zhu, Liancheng Fan, et al.. (2020). Surface-enhanced Raman spectroscopy of preoperative serum samples predicts Gleason grade group upgrade in biopsy Gleason grade group 1 prostate cancer. Urologic Oncology Seminars and Original Investigations. 38(6). 601.e1–601.e9. 7 indexed citations
15.
Pan, Jiahua, Xiaoguang Shao, Yinjie Zhu, et al.. (2019). Surface-enhanced Raman spectroscopy before radical prostatectomy predicts biochemical recurrence better than CAPRA-S. International Journal of Nanomedicine. Volume 14. 431–440. 19 indexed citations
16.
Li, Shengxian, Jing Ma, Yun Sun, et al.. (2017). A pilot study of the opposing effects of hyperinsulinemia and hyperandrogenenism on serum lipid profiles and bioactive lipids in women with polycystic ovary syndrome. Zhonghua neifenmi daixie zazhi. 33(8). 644–650. 1 indexed citations
17.
Li, Shengxian, Jing Ma, Yun Sun, et al.. (2016). Discovery of novel lipid profiles in PCOS: Do insulin and androgen oppositely regulate bioactive lipid production?. The Journal of Clinical Endocrinology & Metabolism. 102(3). jc.2016–2692. 67 indexed citations
18.
Ma, Yi, et al.. (2015). Testosterone regulates the autophagic clearance of androgen binding protein in rat Sertoli cells. Scientific Reports. 5(1). 8894–8894. 76 indexed citations
19.
Ma, Yi, Xiaonan Kang, Wen‐Bin Ding, et al.. (2014). Renal Tissue Thawed for 30 Minutes Is Still Suitable for Gene Expression Analysis. PLoS ONE. 9(3). e93175–e93175. 5 indexed citations
20.
Xu, Gang, Ye Lu, Xiaonan Kang, et al.. (2008). [Proteomic analysis in combination with CT diagnosis to distinguish renal cell carcinoma from renal benign masses].. PubMed. 88(12). 858–60. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaofang Shen Breakdown of academic impact, for papers by Qin Huang Breakdown of academic impact, for papers by Qingxia Huang Breakdown of academic impact, for papers by Sujuan Xu Breakdown of academic impact, for papers by Angelika Buczyńska Breakdown of academic impact, for papers by Shuan Zhao Breakdown of academic impact, for papers by Ming Han Breakdown of academic impact, for papers by Ebru Şener Breakdown of academic impact, for papers by Yao Tong Breakdown of academic impact, for papers by Sha Xu
Rankless by CCL
2026